“As a result of these clinical studies, it was shown that adolescents aged 17-12 years old react very well in terms of the appearance of protective antibodies as a result of the introduction of such a drug, much better than the adult population responds to Sputnik V,” RIA Novosti quoted Gunzburg as saying. on the air of the channel "Russia 24".
He added that the adolescent vaccine is Sputnik V, which has been diluted five times.
Alexander Gintsburg also said that the coronavirus pandemic will end when 70-75% of the population will have the required amount of antibodies.